Nalagenetics, a Singapore based BioTech startup that builds solutions for interpreting genetic data, has secured $12.6 million funds in Series A round. This round was co-led by Intudo Ventures and Vulcan Capital, along with participation from strategic investors like A*STAR Accelerate Technologies Pte Ltd, Dexa International, Diagnos Laboratories, etc. The startups plans to use these funds for team expansion and to launch its new services in Singapore, Indonesia and Malaysia.
_
This article has been summarised for quick read. The original article can be read on Deal Street Asia.